Literature DB >> 27859785

Increased monocyte-derived reactive oxygen species in type 2 diabetes: role of endoplasmic reticulum stress.

Robert M Restaino1, Shekhar H Deo1, Alan R Parrish1, Paul J Fadel2, Jaume Padilla3,4,5.   

Abstract

NEW
FINDINGS: What is the central question of this study? Patients with type 2 diabetes exhibit increased oxidative stress in peripheral blood mononuclear cells, including monocytes; however, the mechanisms remain unknown. What is the main finding and its importance? The main finding of this study is that factors contained within the plasma of patients with type 2 diabetes can contribute to increased oxidative stress in monocytes, making them more adherent to endothelial cells. We show that these effects are largely mediated by the interaction between endoplasmic reticulum stress and NADPH oxidase activity. Recent evidence suggests that exposure of human monocytes to glucolipotoxic media to mimic the composition of plasma of patients with type 2 diabetes (T2D) results in the induction of endoplasmic reticulum (ER) stress markers and formation of reactive oxygen species (ROS). The extent to which these findings translate to patients with T2D remains unclear. Thus, we first measured ROS (dihydroethidium fluorescence) in peripheral blood mononuclear cells (PBMCs) from whole blood of T2D patients (n = 8) and compared the values with age-matched healthy control subjects (n = 8). The T2D patients exhibited greater basal intracellular ROS (mean ± SD, +3.4 ± 1.4-fold; P < 0.05) compared with control subjects. Next, the increase in ROS in PBMCs isolated from T2D patients was partly recapitulated in cultured human monocytes (THP-1 cells) exposed to plasma from T2D patients for 36 h (+1.3 ± 0.08-fold versus plasma from control subjects; P < 0.05). In addition, we found that increased ROS formation in THP-1 cells treated with T2D plasma was NADPH oxidase derived and led to increased endothelial cell adhesion (+1.8 ± 0.5-fold; P < 0.05) and lipid uptake (+1.3 ± 0.3-fold; P < 0.05). Notably, we found that T2D plasma-induced monocyte ROS and downstream functional effects were abolished by treating cells with tauroursodeoxycholic acid, a chemical chaperone known to inhibit ER stress. Collectively, these data indicate that monocyte ROS production with T2D can be attributed, in part, to signals from the circulating environment. Furthermore, an interplay between ER stress and NADPH oxidase activity contributes to ROS production and may be a mechanism mediating endothelial cell adhesion and foam cell formation in T2D.
© 2016 The Authors. Experimental Physiology © 2016 The Physiological Society.

Entities:  

Keywords:  NADPH oxidase; PBMCs; endothelial cell adhesion; lipid uptake; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 27859785      PMCID: PMC5600886          DOI: 10.1113/EP085794

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  99 in total

1.  Prior endurance exercise prevents postprandial lipaemia-induced increases in reactive oxygen species in circulating CD31+ cells.

Authors:  Nathan T Jenkins; Rian Q Landers; Sunny R Thakkar; Xiaoxuan Fan; Michael D Brown; Steven J Prior; Espen E Spangenburg; James M Hagberg
Journal:  J Physiol       Date:  2011-09-19       Impact factor: 5.182

2.  Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4.

Authors:  Maria C Wendt; Andreas Daiber; Andrei L Kleschyov; Alexander Mülsch; Karsten Sydow; Eberhard Schulz; Kai Chen; John F Keaney; Bernard Lassègue; Ulrich Walter; Kathy K Griendling; Thomas Münzel
Journal:  Free Radic Biol Med       Date:  2005-04-07       Impact factor: 7.376

3.  Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress.

Authors:  Angelo Avogaro; Elisa Pagnin; Lorenzo Calò
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

4.  Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes.

Authors:  Umut Ozcan; Erkan Yilmaz; Lale Ozcan; Masato Furuhashi; Eric Vaillancourt; Ross O Smith; Cem Z Görgün; Gökhan S Hotamisligil
Journal:  Science       Date:  2006-08-25       Impact factor: 47.728

5.  Endoplasmic reticulum stress and Nrf2 repression in circulating cells of type 2 diabetic patients without the recommended glycemic goals.

Authors:  C Mozzini; U Garbin; C Stranieri; A Pasini; E Solani; I A Tinelli; L Cominacini; A M Fratta Pasini
Journal:  Free Radic Res       Date:  2015-02-06

6.  Effect of ursodeoxycholate and its taurine conjugate on bile acid synthesis and cholesterol absorption.

Authors:  W G Hardison; S M Grundy
Journal:  Gastroenterology       Date:  1984-07       Impact factor: 22.682

7.  Effect of tauroursodeoxycholic acid on biliary lipid composition. A dose-response study.

Authors:  M Muraca; M T Vilei; V Cianci; X T Liu; F Garotta
Journal:  Int J Clin Pharmacol Ther       Date:  1995-07       Impact factor: 1.366

8.  Endoplasmic reticulum stress plays a central role in development of leptin resistance.

Authors:  Lale Ozcan; Ayse Seda Ergin; Allen Lu; Jason Chung; Sumit Sarkar; Duyu Nie; Martin G Myers; Umut Ozcan
Journal:  Cell Metab       Date:  2009-01-07       Impact factor: 27.287

Review 9.  The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling.

Authors:  Suneng Fu; Steven M Watkins; Gökhan S Hotamisligil
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

10.  CD14+ monocytes are vulnerable and functionally impaired under endoplasmic reticulum stress in patients with type 2 diabetes.

Authors:  Takuya Komura; Yoshio Sakai; Masao Honda; Toshinari Takamura; Kouji Matsushima; Shuichi Kaneko
Journal:  Diabetes       Date:  2009-12-03       Impact factor: 9.461

View more
  6 in total

1.  No effect of ascorbate on cutaneous vasodilation and sweating in older men and those with type 2 diabetes exercising in the heat.

Authors:  Naoto Fujii; Robert D Meade; Pegah Akbari; Jeffrey C Louie; Lacy M Alexander; Pierre Boulay; Ronald J Sigal; Glen P Kenny
Journal:  Physiol Rep       Date:  2017-04

2.  Endoplasmic Reticulum Stress Mediates Methamphetamine-Induced Blood-Brain Barrier Damage.

Authors:  Xiaojuan Qie; Di Wen; Hongyan Guo; Guanjie Xu; Shuai Liu; Qianchao Shen; Yi Liu; Wenfang Zhang; Bin Cong; Chunling Ma
Journal:  Front Pharmacol       Date:  2017-09-14       Impact factor: 5.810

3.  Glutathione prevents chronic oscillating glucose intake-induced β-cell dedifferentiation and failure.

Authors:  Jitai Zhang; Hui An; Kaidi Ni; Bin Chen; Hui Li; Yanqin Li; Guilian Sheng; Chuanzan Zhou; Mengzhen Xie; Saijing Chen; Tong Zhou; Gaoxiong Yang; Xiufang Chen; Gaojun Wu; Shengwei Jin; Ming Li
Journal:  Cell Death Dis       Date:  2019-04-11       Impact factor: 8.469

4.  The Mitochondrial Antioxidant SS-31 Modulates Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy in Type 2 Diabetes.

Authors:  Irene Escribano-López; Aranzazu M de Marañon; Francesca Iannantuoni; Sandra López-Domènech; Zaida Abad-Jiménez; Pedro Díaz; Eva Solá; Nadezda Apostolova; Milagros Rocha; Víctor M Víctor
Journal:  J Clin Med       Date:  2019-08-28       Impact factor: 4.241

5.  Glutathione prevents high glucose-induced pancreatic fibrosis by suppressing pancreatic stellate cell activation via the ROS/TGFβ/SMAD pathway.

Authors:  Jitai Zhang; Juan Bai; Qian Zhou; Yuxin Hu; Qian Wang; Lanting Yang; Huamin Chen; Hui An; Chuanzan Zhou; Yongyu Wang; Xiufang Chen; Ming Li
Journal:  Cell Death Dis       Date:  2022-05-06       Impact factor: 9.685

6.  Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects.

Authors:  Anthony H Cincotta; Eugenio Cersosimo; Mariam Alatrach; Michael Ezrokhi; Christina Agyin; John Adams; Robert Chilton; Curtis Triplitt; Bindu Chamarthi; Nicholas Cominos; Ralph A DeFronzo
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.